Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study
<i>Background and Objectives</i>: In October 2018, the International Federation of Gynecology and Obstetrics (FIGO) revised its classification of advanced stages of cervical cancer. The main points of the classification are as follows: stage IIIC is newly established; pelvic lymph node m...
Main Authors: | Masahiro Kagabu, Takayuki Nagasawa, Shunsuke Tatsuki, Yasuko Fukagawa, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Tadahiro Shoji, Tsukasa Baba |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/6/548 |
Similar Items
-
Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions
by: Masahiro Kagabu, et al.
Published: (2020-03-01) -
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas
by: Tadahiro Shoji, et al.
Published: (2021-12-01) -
Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer
by: Tadahiro Shoji, et al.
Published: (2021-05-01) -
Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy
by: Raminta Stuopelytė, et al.
Published: (2023-04-01) -
Treatment for Locally Resectable Stage IIIC1 Cervical Cancer: A Retrospective, Single-Institution Study
by: Yoko Kashima, et al.
Published: (2023-02-01)